Results 181 to 190 of about 3,330,143 (311)

5-Aza-2′-deoxycytidin (Decitabine) increases cancer-testis antigen expression in head and neck squamous cell carcinoma and modifies immune checkpoint expression, especially in CD39-positive CD8 and CD4 T cells

open access: yesNeoplasia: An International Journal for Oncology Research
Failure of immunotherapy in head and neck squamous cell carcinoma (HNSCC) patients represents an unmet need to augment leverage of adaptive immunity. Immunogenic cancer-testis antigen (CTA) expression as well as lymphocyte differentiation and function ...
Adrian Fehn   +10 more
doaj  

Facilitators and barriers to implementing patient-reported outcomes in clinical oncology practice: a systematic review based on the consolidated framework for implementation research

open access: yesImplementation Science Communications
Background In clinical oncology practice, patient-reported outcomes (PROs) are essential for assessing the symptom burden, quality of life, and psychological status of patients. However, there remains a gap between the use of PROs in an oncologic setting
Jianxia Lyu   +6 more
doaj   +1 more source

Multi-Task Learning for Integrated Automated Contouring and Voxel-Based Dose Prediction in Radiotherapy [PDF]

open access: yesarXiv
Deep learning-based automated contouring and treatment planning has been proven to improve the efficiency and accuracy of radiotherapy. However, conventional radiotherapy treatment planning process has the automated contouring and treatment planning as separate tasks.
arxiv  

Highlights in head and neck cancer [PDF]

open access: yes, 2014
Abstract: During the 2020 annual ASCO meeting, the most recent advances in squamous cell carcinoma of the head and neck as well as nasopharyngeal carcinoma were discussed. First of all, weekly cisplatin proved to be non-inferior to three-weekly cisplatin in the postoperative setting. Next, several interesting studies in both locoregionally advanced and
openaire   +7 more sources

Dose perturbation resulting from gold fillings in patients with head and neck cancers

open access: bronze, 1979
Valsa Thambi   +3 more
openalex   +1 more source

Immunosuppressive substance in the sera of head and neck cancer patients [PDF]

open access: bronze, 1988
Noboru Yamanaka   +3 more
openalex   +1 more source

Induction therapy in head and neck cancer. A comparison of two regimens [PDF]

open access: bronze, 1986
Monica B. Spaulding   +6 more
openalex   +1 more source

Home - About - Disclaimer - Privacy